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Ectodermal dysplasia (ED) is a group of syndromes
characterized by abnormalities of structures of ectoder-
mal origin. Up to now more than 150 different syn-
dromes are known. Affected ectodermal structures are
mainly hair, teeth, nails and sweat glands. ED can be
classified by mode of inheritance (autosomal dominant,
autosomal recessive and X-linked), by additional clinical
symptoms (e.g. facial abnormalities) or by the structures
involved. Hypohidrotic or “classical” ED (HED) is caused
by mutations in the genes EDA, EDAR and EDARADD.
Mutations in the X-linked EDA gene underlie most
cases. EDAR and EDARADD are known to be associated
with both autosomal dominant and autosomal recessive
forms of HED. As many ED forms show overlapping
clinical phenotypes, often many genes have to be ana-
lyzed to identify the causative mutation in a patient,
therefore Sanger sequencing frequently takes several
months and is laborious and cost-intensive. We have
designed an accurate and fast molecular test for the 6
most common ED genes using next-generation sequen-
cing. We developed a novel PCR-based protocol on a
Roche 454 Junior platform for mutation screening of the
genes EDA, EDAR, EDARADD, TP63, GJB6 and
WNT10A. The verification and validation process was
finished in October 2011, and the “ED panel” is now the
routine diagnostic test for ED in our institute. During
the last months several mutations in different genes
could be identified with this method. A definitive diag-
nosis could be made rapidly in a number of so far
„unsolved cases”. In summary, the next generation
sequencing approach has the potential to increase the
diagnostic sensitivity by expanding the number of genes
that can be screened in parallel while also reducing
expenditure of time and costs.
Published: 25 May 2012
doi:10.1186/1746-160X-8-S1-O1
Cite this article as: Gabriel et al.: Parallel testing of several genes (panel-
testing) in patients with ectodermal dysplasia using next-generation
sequencing. Head & Face Medicine 2012 8(Suppl 1):O1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
diagenos: Humangenetische Praxis, Osnabrück, Germany
Gabriel et al. Head & Face Medicine 2012, 8(Suppl 1):O1
http://www.head-face-med.com/content/8/S1/O1
HEAD & FACE MEDICINE
© 2012 Gabriel et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.